Tag: biotechnology
-
Science & Enterprise Year in Review
Our most-viewed new story is from an academic/industry research team in Australia that tells how a synthetic cannabidiol, or CBD, compound is as effective as current antibiotics against a class of microbes.
-
Infographic – Biotech Index Zooms to New High
Since October, the Nasdaq Biotechnology Index rose steadily to a new high for the year, as shown in this weekend’s infographic.
-
Synthetic Bio Cancer Immunotherapy Company Acquired
A biotechnology company creating synthetic proteins that invoke the immune system to fight cancer is being acquired by drug maker Astellas Pharma.
-
Commentary – New Models Needed for Antibiotic Resistance
Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge.
-
Tomato Genetics Altered for Urban Farms
Plant scientists used a genome-editing technique to produce varieties of tomatoes better suited for growing on urban farms and other small plots.
-
FDA Blocks Monthly HIV Drug Combo
The U.S. Food and Drug Administration rejected a combination of experimental and existing drugs given once a month to treat HIV.
-
Engineered Viruses Licensed for Cancer Therapies
A biotechnology company developing cancer immunotherapies with synthetic viruses is licensing its technology to Takeda Pharmaceuticals.
-
Small Biz Grant Funds PTSD Diagnostic, Treatment
A company creating diagnostics and a treatment for post-traumatic stress disorder, or PTSD, is receiving initial funding to develop its products.
-
Viruses Altered to Boost Gene Therapy Delivery
Researchers in Sweden developed a process to improve the targeting of benign viruses for delivering gene therapies to the brain.
-
Synthetic Bio Company Acquired in $2.35B Deal
A company developing protein-like therapies for cancer from synthetic bacteria is being acquired by drug maker Sanofi in a deal valued at $2.35 billion.